Iatrogenic Cushing's syndrome in children following nasal steroid

8Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

UNLABELLED: Cushing syndrome is a hormonal disorder caused by prolonged exposure of body tissue to cortisol. We report two cases of iatrogenic Cushing's syndrome in two Nigerian children following intranasal administration of aristobed-N (Betamethasone + Neomycin) given at a private hospital where the children presented with feature of adenoidal hypertrophy. Two months into treatment children were noticed to have developed clinical and laboratory features of iatrogenic Cushing's syndrome with critical adrenal suppression. Serum cortisol (at presentation): 1(st) patient: 12nmol/L (reference range 240-618), 2(nd) PATIENT: 1.69nmol/L. Serum cortisol (3 months after weaning off steroid): 343.27 nmol/L (within normal range for the first patient; second patient newly presented and has just begun steroid weaning off process. The serum cortisol level one month into weaninig off process was 128 nmol/L). Unsupervised topical steroid administration in children can cause adrenal suppression with clinical features of Cushing's syndrome.

Cite

CITATION STYLE

APA

Oluwayemi, I. O. ludare, Oduwole, A. O. lufunmilayo, Oyenusi, E., Onyiriuka, A. N. didi, Abdullahi, M., Fakeye-Udeogu, O. B. enedicta, … Kouyate, M. (2014). Iatrogenic Cushing’s syndrome in children following nasal steroid. The Pan African Medical Journal, 17, 237. https://doi.org/10.11604/pamj.2014.17.237.3332

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free